share_log

藥明康德：海外監管公告

WUXI APPTEC: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Mar 18 10:30
Summary by Moomoo AI
药明康德（股份代號：2359）於2024年3月18日發布海外監管公告，公佈了董事會審計委員會對會計師事務所2023年度履職情況評估及監督職責的報告。報告指出，經股東大會審議通過，公司2023年度財務報告審計機構為德勤華永會計師事務所及德勤香港。兩家會計師事務所均出具了標準無保留意見的審計報告，認為药明康德的財務報表在所有重大方面公允反映了公司的財務狀況及經營成果。審計委員會對德勤華永和德勤香港的專業資質、業務能力及獨立性進行了嚴格審查，並對其2023年度的履職情況給予正面評價，認為其符合公司的審計工作要求。
药明康德（股份代號：2359）於2024年3月18日發布海外監管公告，公佈了董事會審計委員會對會計師事務所2023年度履職情況評估及監督職責的報告。報告指出，經股東大會審議通過，公司2023年度財務報告審計機構為德勤華永會計師事務所及德勤香港。兩家會計師事務所均出具了標準無保留意見的審計報告，認為药明康德的財務報表在所有重大方面公允反映了公司的財務狀況及經營成果。審計委員會對德勤華永和德勤香港的專業資質、業務能力及獨立性進行了嚴格審查，並對其2023年度的履職情況給予正面評價，認為其符合公司的審計工作要求。
Ming Kand Pharmaceuticals (stock code: 2359) issued an Overseas Regulatory Notice on 18 March 2024 and announced the Board's Audit Committee's report on the audit committee's 2023 performance assessment and oversight responsibilities. The report states that, subject to the approval of the Annual General Meeting, the auditors of the Company's financial statements for 2023 are the firm's Accounting Firm and Delkin Hong Kong. Both accounting firms have issued standard unreserved audit reports that consider that Ming Kund's financial statements fairly reflect the financial condition and operating results of the company in all material respects. The Audit Committee conducted a rigorous review of the professional qualifications, business capacity and independence of DQin Huaywing and DQin Hong Kong, and gave a positive assessment of their performance in 2023 and considered them to be in line with the company's audit work requirements.
Ming Kand Pharmaceuticals (stock code: 2359) issued an Overseas Regulatory Notice on 18 March 2024 and announced the Board's Audit Committee's report on the audit committee's 2023 performance assessment and oversight responsibilities. The report states that, subject to the approval of the Annual General Meeting, the auditors of the Company's financial statements for 2023 are the firm's Accounting Firm and Delkin Hong Kong. Both accounting firms have issued standard unreserved audit reports that consider that Ming Kund's financial statements fairly reflect the financial condition and operating results of the company in all material respects. The Audit Committee conducted a rigorous review of the professional qualifications, business capacity and independence of DQin Huaywing and DQin Hong Kong, and gave a positive assessment of their performance in 2023 and considered them to be in line with the company's audit work requirements.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more